TSPO and graft versus host disease: (19) performed a prospective pilot study of PET/CT using [18F]-flutriciclamide ([18F]GE-180), an already-reported third-generation high-affinity TSPO radiotracer, in 8 allogeneic HSCT adult recipients with a clinical suspicion of acute GI-GvHD.